◀ Back to JUN
ECM1 — JUN
Text-mined interactions from Literome
Ahn et al., Gene Ther 2004
(Diabetic Nephropathies) :
This investigation was undertaken to test the hypothesis that
AP-1 plays an important role in
ECM gene expression, and to develop a molecular therapeutic strategy based on decoy oligodeoxynucleotides ( ODN )
Lake et al., Biomaterials 2013
:
Results from transfection of CAT/a5-promoter plasmids, Western blot and EMSA analyses indicated that
ECM/35d significantly increase expression of a5 in HCECs as a
result of alteration in the expression and DNA binding of the transcription factors NFI, Sp1,
AP-1 and PAX6